Tagworks Pharmaceuticals

About:

Tagworks Pharmaceuticals is a privately held biotech company

Website: https://www.tagworkspharma.com/

Top Investors: New Enterprise Associates, Novartis Venture Fund, Lightstone Ventures, Ysios Capital, BIF Partners

Description:

Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. Tagworks develops In vivo chemistry to improve the efficacy of cancer therapies and to enable novel approaches in companion diagnostics. The company’s facilities are located at the Radboud University Medical Center in Nijmegen. Founded in 2011, Tagworks is a spin-out of Philips Healthcare, and originates from Philips’ molecular imaging expertise.

Total Funding Amount:

$65M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nijmegen, Gelderland, The Netherlands

Founded Date:

2011-01-01

Contact Email:

info(AT)tagworkspharma.com

Founders:

Marc Robillard, Raffaella Rossin

Number of Employees:

11-50

Last Funding Date:

2023-06-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai